Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0950
-0.0031 (-3.16%)
Apr 1, 2025, 3:57 PM EST

PVCT Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-4.76-3.1-3.55-5.54-6.68
Upgrade
Depreciation & Amortization
0.010.010.010.010.24
Upgrade
Stock-Based Compensation
1.28000.020.13
Upgrade
Other Operating Activities
0.050.050.050.020.07
Upgrade
Change in Accounts Receivable
0-00--
Upgrade
Change in Accounts Payable
-0.57-0.420.810.33-0.17
Upgrade
Change in Unearned Revenue
-0.62-0.56-0.992.5-
Upgrade
Change in Other Net Operating Assets
1.331.450.621.642.31
Upgrade
Operating Cash Flow
-3.28-2.57-3.04-1.01-4.09
Upgrade
Short-Term Debt Issued
2.852.481.633.16-
Upgrade
Long-Term Debt Issued
----3.29
Upgrade
Total Debt Issued
2.852.481.633.163.29
Upgrade
Short-Term Debt Repaid
-0.31-0.28-0.26-0.25-0.11
Upgrade
Long-Term Debt Repaid
-0.1----
Upgrade
Total Debt Repaid
-0.41-0.28-0.26-0.25-0.11
Upgrade
Net Debt Issued (Repaid)
2.452.191.372.913.18
Upgrade
Issuance of Common Stock
0.3--0.960.42
Upgrade
Other Financing Activities
---0.15-
Upgrade
Financing Cash Flow
2.752.191.374.023.6
Upgrade
Foreign Exchange Rate Adjustments
-0-0.02-0-0-0.01
Upgrade
Net Cash Flow
-0.54-0.4-1.683.01-0.49
Upgrade
Free Cash Flow
-3.28-2.57-3.04-1.01-4.09
Upgrade
Free Cash Flow Margin
-532.15%-461.17%-307.52%--
Upgrade
Free Cash Flow Per Share
-0.01-0.01-0.01-0.00-0.01
Upgrade
Levered Free Cash Flow
-4.58-1.16-0.88-6.941.06
Upgrade
Unlevered Free Cash Flow
-4.43-1.03-0.77-6.342.15
Upgrade
Change in Net Working Capital
1.61-0.52-1.013.48-4.86
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.